Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications cost effectiveness 13 valent pneumococcal conjugate vaccine compared 10 valent vaccin
… Diseases (ESPID) Share on: Monday, May 9 - Friday, May 13, 2022 Conference Website Research coauthored by RTI Health … the public health impact of switching to pediatric 13-valent pneumococcal conjugate vaccine in the near-term and …
… Comparing the public health impact of a 15- or 20-valent pneumococcal conjugate vaccine paediatric national … conjugate vaccine programs result in substantial cost-savings and cases averted in the United …
… Meningococcal, polysaccharide (MPSV4) Mumps Pertussis Pneumococcal conjugate (PCV) Pneumococcal polysaccharide … studies Conjoint analyses Decision-analytic models (cost effectiveness, budget impact) Dynamic disease transmission …
… to Increase Vaccination in Older Adults Worth the Cost? Share on: October 5, 2021 Gaining optimal vaccination … recommend that older adults in the US be vaccinated for vaccine-preventable influenza, whooping cough, shingles, and pneumococcal disease. But the number vaccinated is considered …
… Cross-Sectional Survey of Pneumococcal Vaccine Prescribers OPPORTUNITY The CDC’s Advisory Committee … beliefs, and preferences for potential changes to pneumococcal disease immunization recommendations among …
… health goals. Given the human and economic burden of vaccine-preventable disease, understanding the factors behind … The key vaccines studied included seasonal influenza; pneumococcal; herpes zoster; and tetanus, diphtheria, and … research can be found at PharmacoEconomics - Open, doi: 10.1007/s41669-021-00262-x . To learn more about the methods …
… ISPPD-12 (International Society of Pneumonia and Pneumococcal Diseases) Share on: Sunday, June 19 - Friday, … at the ISPPD-12 (International Society of Pneumonia and Pneumococcal Diseases). Estimating the historical … K, Grant L, Barry R, Huang L, McDade C , Wilson M . Non-vaccine serotype population-level trends for invasive …
… disease were avoided. Image IPD = Invasive pneumococcal disease Economic Impact In addition to … sickness, disability, and death, pediatric immunization is cost saving. A separate study including researchers from … diseases in the US . Pediatrics. 2022 Jul 13. Carrico J , La EM, Talbird SE , Chen YT, Nyaku MK, …
… Priorities, Real-World Evidence, and the Safety and Effectiveness of COVID-19 Vaccines Share on: November 2, … Issues such as mixing and matching vaccines, boosters, and vaccine use in children are fundamentally changing that … methods, and support for performing studies. The Biologics Effectiveness and Safety (BEST) System supports the Sentinel …
… Real-World Comparative Effectiveness Analysis for Use in Cost-Effectiveness Modeling in Multiple Sclerosis …